Vol. 33 No. 146 (1992), Clinical cases
Vol. 33 No. 146 (1992)

Carbacepine-induced type II pseudohypoparathyroidism

Clinical cases
Published 1992-11-01
M. Herrera Martín
Servicio de Pediatría. Hospital General de Segovia. Segovia.
V. Nebreda Pérez
Servicio de Pediatría. Hospital General de Segovia. Segovia.
C. Reig del Moral
Servicio de Pediatría. Hospital General de Segovia. Segovia.
J. García Velázquez
Servicio de Pediatría. Hospital General de Segovia. Segovia.
E. García Jiménez
Servicio de Pediatría. Hospital General de Segovia. Segovia.
N. Burguillo Jiménez
Servicio de Pediatría. Hospital General de Segovia. Segovia.
PDF (Spanish)

Keywords

Metabolic Alterations Of Calcium-Phosphorous Induced By Antiepileptics
Carbamazepine
Pseudohypoparathyroidism Type II

How to Cite

1.
Herrera Martín M, Nebreda Pérez V, Reig del Moral C, García Velázquez J, García Jiménez E, Burguillo Jiménez N. Carbacepine-induced type II pseudohypoparathyroidism. Bol Pediatr. 1992;33(146):381-384. Accessed September 20, 2024. https://boletindepediatria.org/boletin/article/view/1585
Chicago Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

We report a case involving a boby girl with complex partial epilepsy who began a continuous treatment with carbamazepine, at 3 years dose was correct and levels therapeutic. She presented biochemically with pseudohypoparathyroidism type II which normalized 45 days after the suspension of the drug and remained normal 90 to 120 days later.

 

PDF (Spanish)
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 1992 Boletín de Pediatría